IGF1R and lymphedema: To study the effect of inhibiting IGF1R signaling in the lymphedema model, we treated mice daily with linsitinib (also known as OSI-906),17 a small molecule inhibitor of the tyrosine kinase activity of IGF1R, beginning the day of surgery until 17 days post-surgery.